MOR Wealth Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
MOR Wealth Management's ABCL Position: Q3 2026 in Review
MOR Wealth Management held its AbCellera Biologics (ABCL) position steady in Q3 2026 at 33,000 shares worth $481K. The position accounts for 0.18% of the portfolio, ranked #76.
MOR Wealth Management first reported a position in ABCL in Q4 2025 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- MOR Wealth Management held 33,000 shares of AbCellera Biologics worth $481K as of Q3 2026.
- MOR Wealth Management left its AbCellera Biologics share count unchanged in Q3 2026.
- AbCellera Biologics made up 0.18% of MOR Wealth Management's portfolio in Q3 2026, its #76 holding.
- MOR Wealth Management first reported a position in AbCellera Biologics in Q4 2025 and has held it in 4 quarters since.
- 164 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on MOR Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.